DatasetName,FXR1_S(380) FXR1_S(390) FXR1_S(393) FXR1_S(396) FXR1_S(403) FXR1_S(406) FXR1_S(407) FXR1_S(409) FXR1_S(410) FXR1_S(413) FXR1_S(415) FXR1_S(420) FXR1_S(423) FXR1_S(432) FXR1_S(438) FXR1_S(464) FXR1_S(478) FXR1_S(485) FXR1_S(494) FXR1_S(574) FXR1_S(578) FXR1_S(585) FXR1_S(587) FXR1_T(401) FXR1_T(411) FXR1_T(483) FXR1_T(488) FXR1_T(491) FXR1_T(511) FXR1_T(597) FXR1_T(611) FXR1_Y(477),FXR1_S(19) FXR1_S(391) FXR1_S(467) FXR1_S(499) FXR1_S(5) FXR1_S(546)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,0.5107383049964533,
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.499691402791071,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.5056992617840677,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,0.49861045277814825,
ZX2022_Control Replicate 2,0.4952400683347956,
HS2024_6_B_T3,0.5078641383628051,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.5088476083150506,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.5020645948123416,0.35655483486896217
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.4981881723215334,
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,0.5042316990856226,
RB2022_5_PreEndurance,0.5010887084197512,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.5325002490126538,
WZ2023_Pu_010_30min,0.4998389743520055,0.3504143304976775
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,0.49994032146902595,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.5047993354182446,
RB2022_8_RecoveryEndurance,0.496052084570451,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.5077778807031451,
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,0.5093320912792426,
PG2020_Intensity 8h_C,,
AH2018_SILAC_MR_2_N,0.5001459344236822,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.49335240785183093,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,0.5043536487783645,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5078318762348222,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,0.49877409255002736,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,0.49657906477865876,
GF2025_P6_Sph,0.5022931494510179,
RB2022_2_PreSprint,0.48983077229439204,
ZX2022_CB treated Replicate 3,0.4963966892095751,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.4921427731706405,0.3517218560787774
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,0.5008492529950259,0.3640182819579069
WZ2023_Pu_005_10min,0.4929590454235177,0.36100964619618897
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.4982014210282841,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,0.5113707539011387,
WZ2023_Pu_025_30min,0.507460025819453,
AH2018_SILAC_MR_2_X,0.5028302786805389,
HS2024_4_PD_T2,0.5087261976512814,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,0.5091633315597586,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5030163289718661,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,0.5014443460952527,
EJN2021_3_Rest_Basal,0.5000176737152191,
CR2017_Ratio Replicate 1.3,0.5134446199048156,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.5019559683950898,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.504002168191312,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,0.5056488155772817,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.49174867209319206,0.34815794474248946
CK2022_11 40-1,0.49807030660235174,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.5035311467334626,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5039481292962801,
FSO2013_Ratio H/L normalized Rep2,,
WZ2023_Pu_005_20min,0.4967714811295319,0.36403007958354633
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5081418687782892,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,0.5104139175813075,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.5080867769811465,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,0.5110010240537474,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,0.498362012999614,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.5029434131728026,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.5017839796510009,
CK2022_1 200-1,0.5140970291328287,
PG2020_Intensity Mock_10h_D,0.49636336990009433,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,0.4978063294769464,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5046006078592309,
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.5052120404387865,
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.49597011717111894,
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,0.5010082279828065,
AH2018_LFQ_M_2_C,0.507891013461965,
CK2022_3 40-1,0.5031901068324819,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.5124415477457017,
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.5084276368940849,
EJN2021_5_Rest_Basal,0.5055983342466676,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,0.507660614023956,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.5024168878860765,
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,0.5090966390937495,
RB2022_1_PostEndurance,0.5040623901085466,
CR2017_Ratio Replicate 3,0.5116868376137733,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,0.4835165306995972,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.5004760794206496,
HS2024_8_I_T3,0.5024143254715817,
CF2017_EOC 3,0.5026532964310566,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,0.49897643555277327,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.4979098753213337,0.3632976463517461
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.5030918249072405,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.4984337314221645,
KS2014_Intensity N3,0.49663202027721853,0.32152526170555934
RB2022_4_RecoveryEndurance,0.4947087723106119,
RB2022_5_RecoveryEndurance,0.5067158062192232,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5062541785635094,
FSO2013_Ratio H/M normalized Rep2,,
RAM2015_Log2 A,,
HS2024_8_PD_T1,0.502750484747958,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,0.5016363756772582,
KS2014_Intensity E15_2,0.49501238133988357,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,
HS2024_7_I_T1,0.5112379420459806,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,0.49528160498814744,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.5016512574655957,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,0.5119756843977293,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5328657762977228,
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.35503384230723306
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,0.4997944785838092,
AH2018_SILAC_IT_3_X,0.5023194543754134,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.49976346671355854,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,0.4991488094669318,
RB2022_6_PreSprint,0.5137509539807511,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.5050816682029158,
DL2023_control-1,0.5013369068681647,
AR2021_ALG 10 μM,0.5080720635614805,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.5042533933448218,
EJN2021_4_Rest_Ins,0.4992261938498649,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.513966468030729,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,0.5000874269695973,
EJN2021_1_Rest_Ins,0.5051473899977177,
HH2022_Reporter intensity 3,0.5081474395524982,0.3508500069902327
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.5060958533240539,
JW2021_After_3,,
GF2025_P8_Sph,0.5089938226589854,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.5037248895062588,
CK2022_11 200-1,0.5004889430383783,
CK2022_12 200-1,0.4991700544384644,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.5000315634853202,
WZ2023_Su_010_20min,0.4970484594771719,0.36755932212076514
AH2018_TMTMS2_2_N,0.5083281958396104,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.5014697838177541,0.3569734647324297
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.3340321168500018
AH2018_TMTMS3_Pool,0.5096471142960707,
KS2014_Intensity N4,0.4936854089340191,0.37114303772568946
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,
CK2022_14 200-1,0.5005276761372832,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,0.5023457321264309,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.5079310451739981,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,0.5063623643608188,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.49768441655275075,
GF2025_P1_Adh,0.4999499080149202,
GF2025_P1_Sph,0.49675039885190636,
EJN2021_5_Ex_Basal,0.5011239433465147,
HS2024_7_I_T3,0.5002199157191485,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.4896684805490672,0.3525541423296923
CF2017_EOC 1,0.5064718281802065,
CK2022_3 200-1,0.5149808135036802,
AH2018_LFQ_IT_3_C,0.5043568655041116,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,0.493958616099039,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,0.5048211344042834,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,0.49697926870658965,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,0.5122329601400545,
CK2022_2 40-1,0.5028697392281994,
RB2022_1_PostSprint,0.5013750266767671,
CK2022_4 200-1,0.5134554810813972,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.49947969641795165,
AR2021_ALG 1 μM,0.5230754689041155,
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,0.5053192231376566,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.5016434127960819,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5165405095806984,
CK2022_9 16-1,0.4952883605431407,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5018257142919795,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,
CK2022_16 16-1,0.49714678338544155,
FS2019_db/db3,,
CK2022_15 40-1,0.4999143438447326,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.4988255653342251,0.3559985002681589
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.501870071606374,0.3499932168687532
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.5035007279599041,
HS2024_5_PD_T3,0.5027606491389764,
AH2018_TMTMS3_3_X,0.5110748895659548,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,0.5093235359647825,
KBE2022_Log2_Ex_27_U,,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.5064538982316986,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,0.5029788049940515,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,0.5032877269292478,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.49519761493577463,
RN2012_L13,,
LG2023_Control-1_intensity,0.510668679257103,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.5024761878546411,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.4977381166769381,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.5090218260302711,
HH2022_Reporter intensity 6,0.49886240141392263,
RB2022_2_RecoveryStrength,0.48409045813282003,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.49608579364843813,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.5111562097800995,
GF2025_P3_Adh,0.5066379345442796,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.5061611613374848,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.4991955961262483,
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,0.5092416889943309,
LG2023_GSK3α-3_intensity,0.5116903617200219,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,0.5143490551198192,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,0.5006253845026905,
RB2022_7_RecoverySprint,0.5008467391279967,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,0.501841557217359,
AH2018_LFQ_1_X,0.5043126049922385,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5032650659209406,0.3644723076064011
HH2022_Reporter intensity 1,0.5083630639743786,0.3521793092856935
HH2022_Reporter intensity 2,0.5083547710271303,0.3524694774770174
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.49413760655031447,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,0.5065919397890449,
CR2017_Ratio Replicate 2,0.5004745354796996,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,
AR2021_KD 72h,0.5088608980573308,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.5106832053254535,
KBE2022_Log2_Ex_9_U,,
AH2018_SILAC_M_3_N,0.4979840511171328,
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.49669363543449746,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,0.49998678283829395,
PG2020_Intensity 10h_A,,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.5026473140743115,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.5011907538792715,
RB2022_7_RecoveryEndurance,0.5056104752579216,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,0.5025907379522722,
TM2022_S2.12h.B,,
RN2012_L15,,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.5026690391848144,0.34309747759622056
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5033186895204788,
RB2022_1_PreSprint,0.4931259207135041,
HS2024_4_I_N1,0.5016919755908809,
CK2022_7 200-1,0.5105530559481278,
CK2022_5 200-1,0.5107135128252925,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,0.49960297013729327,
AH2018_LFQ_2_C,0.5064021596842663,
AH2018_SILAC_MR_1_X,0.5056850954505453,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.5015768006558246,0.33825491601625207
AH2018_SILAC_3_C,0.5026497803804207,
EJN2021_5_Rest_Ins,0.5049297959522905,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,
CK2022_4 16-1,0.5019736544428808,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,0.504887376090324,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.5073864812274224,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,,
AH2018_SILAC_IT_2_N,0.50378967490648,
AH2018_SILAC_IT_1_X,0.5027654722373096,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,0.4932631658530955,
UK2020_UA_2,0.5049688909603467,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5037563788198053,
WZ2023_Pe_025_20min,0.48301324018662467,0.3591852033841079
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.5045641870617374,
HS2024_4_I_N2,0.5053325409755823,
AH2018_TMTMS2_3_N,0.511208963752476,
RN2012_H06,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.5033474910616613,
WZ2023_Su_005_30min,0.500079352266777,0.35458130234588614
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,0.5044368678210014,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5009179466000513,
WZ2023_Su_025_10min,0.48969488744066536,0.34393423991232325
AH2018_LFQ_IT_4_X,0.5019496294859335,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,0.49677152964126803,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.4995890544554616,0.35308386470439457
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,0.4896686008746895,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,0.5111934689414195,
EP2017_Pervanadate R#1 log2 ratio,0.5145052205680851,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,0.5121482919491611,
KS2014_Intensity,0.5077806066287683,0.36353137430307214
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,
LY2019_P7+,0.5020761139816028,
EP2017_Untreated R#1 normalized log2 ratio,0.48783229163982417,
RN2012_L10,,
PG2020_Intensity 4h_C,,
EP2017_Mitotic R#3 normalized log2 ratio,0.5013178454414905,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.5025226241196936,0.3492502664707568
RB2022_8_PostStrength,0.5069131049257778,
AH2018_SILAC_IT_2_X,0.5021595701612336,
HS2024_4_B_T3,0.5075917779061484,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,0.5004804174002168,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,0.49974313256191777,
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5016180506123153,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5003365500628434,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.49469529477884666,
GF2025_P9_Sph,0.504937071018166,
CK2022_6 200-1,0.5113615527383649,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.511524966761513,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,0.5026753305980579,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.5048062446610174,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,0.5063538081043184,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,
EP2017_Untreated R#3 normalized log2 ratio,0.502865213837826,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5105579480871018,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.4993667548491078,
RB2022_7_PostEndurance,0.5139816811956907,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.50120404614269,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.5043874770174451,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.5054952044777598,
KBE2022_Log2_Ex_29_T,,
HS2024_7_I_T2,0.4979594831820168,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,0.5046257781366504,
FR2021_Intensity.M,,
RB2022_2_PostSprint,0.49962499005590894,
AH2018_SILAC_MR_3_N,0.5052942747579123,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.5011845810544989,
PG2020_Intensity CT_C,,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,0.5032546043551028,
RB2022_2_PostStrength,0.5022545553421062,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.4996995434901083,
HS2024_8_PD_T2,0.501819173793788,
FS2019_Ctr2,,
RB2022_6_PreEndurance,0.5030188065494506,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,0.501295878146248,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,0.49919987196632143,
CR2017_Ratio Replicate 2.3,0.5076531091393545,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.5149476692676618,
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.5010953366090541,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.509096426347703,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,0.50177845387577,
RAM2015_Log2 B,,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,0.5000803967583372,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,0.5057982817106571,
UK2020_HCM_5,0.503860180093741,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,0.49836127967941773,
PG2020_Intensity Mock_10h_B,,
WZ2023_Su_025_30min,0.49600262483587926,0.3502413323932487
AH2018_LFQ_4_N,0.5053717854698955,
CR2017_Ratio Replicate 1.2,0.5125388068299703,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,0.5000092940962169,
HS2024_8_I_N1,0.5027338317911589,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.4934804262349531,
AH2018_SILAC_M_1_X,0.5062132792626552,
RB2022_7_PreEndurance,0.4914723315206502,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,0.4979025476391238,
LY2019_P6+,0.5054287849003346,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.49877340628218325,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,0.5038625968830568,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,0.5113444099727953,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.5089118508507742,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,0.49352361060392486,
KS2014_Intensity C5,0.5064653309915949,0.35274587473501384
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,0.5009607988947281,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.5063853136006005,
RB2022_3_PostStrength,0.5102354823679033,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.504794253696016,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.5027245554750547,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,
AH2018_LFQ_2_X,0.5046709448026852,
PG2020_Intensity 2h_B,,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,0.49965980272956795,
KS2014_Intensity E15_3,0.496773412029111,
GF2025_P3_Sph,0.4970602582418829,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.5057032383355895,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.3492770517346731
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.5044929706017489,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,0.4949274090643079,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.5037550994165307,
ZQ2022_N1,,
LY2019_P6-,0.5083239679461812,
RM2024_Intensity D2-3,,
UK2020_HCM_1,0.5041956514473546,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,
AH2018_LFQ_3_N,0.5053827295624826,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,0.5041741662182125,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,0.5114367119442826,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,0.5018543459049035,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,0.5111218169429982,
HS2024_5_PD_T2,0.5031151929029247,
WZ2023_Su_025_20min,0.49575708752747805,0.3491843362454004
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.5068694810575805,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.49993796991691536,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,0.5109899700932807,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,0.5013632237300454,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.5024927073166571,
EP2017_Pervanadate R#3 log2 ratio,0.5079465988914963,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,0.496538945459327,
AH2018_SILAC_MR_3_C,0.5031285109264576,
AH2018_LFQ_M_4_C,0.5077265181884547,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,0.4998628613769237,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,0.5019464663799651,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,0.5058564601318621,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,0.5011234292677585,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.4971181169815256,0.3484795729118173
HS2024_8_PD_T3,0.5008831065345969,
EJN2021_3_Ex_Basal,0.5034668765775588,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.501811005829887,0.3644317099684416
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.5246625731694108,
RB2022_1_RecoveryStrength,0.5006391812079443,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,0.4989243912601769,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.5095032543173312,
RB2022_4_PreSprint,0.4905885610700417,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.508672900178102,
HS2024_8_I_N2,0.5036015979267202,
RB2022_3_RecoveryStrength,0.4964456040146093,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5063913196809584,
LY2019_P8+,0.5065629753486027,
RB2022_2_RecoveryEndurance,0.49607256031051317,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,0.5038165472434234,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.3587862164238505
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.5038667139700057,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.504524068361893,
LY2019_P2-,0.5071579421913177,
AH2018_LFQ_IT_1_X,0.5060545471024746,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,0.51429126630503,
WZ2023_Pe_005_20min,0.498571300706235,0.3456213262931615
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.5031497311838108,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.4995064993764239,
HS2024_5_B_T2,0.5015186800622811,
HS2024_6_I_T1,0.4975732010949728,
HS2024_5_B_T3,0.4985761375433274,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,
AH2018_TMTMS3_3_N,0.5090116109433509,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.5038226912105115,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5030302486981557,
KBE2022_Log2_Ex_36_T,,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.49700718207677264,0.3456148477589365
KS2014_Intensity C2,0.5069746390420204,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,0.5017719026882613,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5029852974349788,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.5022435680156312,
RBK2021_1332T Late,,
LY2019_P1-,0.49900698424350703,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.5042641105439658,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5029873467822485,0.35280091773153294
ZQ2022_C3,,
EJN2021_3_Rest_Ins,0.5007252209449686,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.48805107258744845,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5019679110933564,0.33623787172086167
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,0.5004393841749728,
KS2014_Intensity N1,0.49680480601651694,0.3570059237948462
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.5067729724000789,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.5036362792164119,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.5052937264735906,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,0.503906840680032,
HS2024_5_I_N1,0.5031278347697986,
HS2024_6_I_N1,,
AR2021_KD 48h,0.5277789891730356,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,0.49397033547870245,
HS2024_5_I_T1,0.5001396418907753,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.496671928144103,0.33206003936846346
KBE2022_Log2_Ex_29_U,,
HS2024_7_B_T1,0.5099430383278244,
AH2018_LFQ_M_2_X,0.5064568645632299,
AH2018_LFQ_IT_4_N,0.5024074892793264,
CK2022_15 200-1,0.5013212264287372,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.5008339567892944,0.361492249887647
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5053937329588701,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.5133779556999275,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.4974420558364407,0.35505009450507224
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.5063651127220082,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5144061946954006,
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,0.5014426796889322,0.3627865192276502
WZ2023_Pe_010_20min,0.4943346758963243,0.3426521315675457
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,0.5128235883836267,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.5057148932297136,0.338455805239736
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,0.49787473872499644,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.5046251070877816,
AH2018_SILAC_M_2_X,0.503228705418784,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.4935178402415409,0.35651970275533945
PG2020_Intensity 6h_C,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.506985216538812,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.511350514995931,
CK2022_15 16-1,0.4975909793204025,
CK2022_3 16-1,0.5024213554887531,
LY2019_P4-,0.5018805283184499,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.5118331959147778,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.4940343490853001,
CK2022_10 16-1,0.4953344059615796,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.3633246869833851
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,0.5043740742264798,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.4963318016638881,
EJN2021_2_Ex_Basal,0.5056606499064312,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.5043960522576422,
AR2021_L41 10 μM,0.49092206984503217,
CF2017_EOC 2,0.5024494170010274,
RB2022_6_PostEndurance,0.5116676409318601,
AH2018_SILAC_1_N,0.5062518049144815,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,0.5048381821284467,
RB2022_7_PreSprint,0.5197718675004612,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,0.49878174163774885,
ZX2022_CB treated Replicate 1,0.49556989681941027,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.5081504177808125,0.3528643376863713
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,0.5065364367528182,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.5084075668901638,
AR2021_L41 1 μM,0.500919805240793,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.5081771671929279,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.49546996827899864,
KS2014_Intensity C4,0.5059501788474793,0.34713654289660756
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.5044324712338325,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,0.5230451917453811,
AH2018_SILAC_IT_3_C,0.5061078016645117,
WZ2023_Pu_025_10min,0.4995769253137936,0.3523627665749672
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.5039186360589369,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.4966195386128486,0.3503765437765371
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.5036881283701593,
KS2014_Intensity C6,0.5068348711820807,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.49823544106153234,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.4972285063964223,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.49895782291260643,
AH2018_SILAC_IT_2_C,0.5059804107892238,
CK2022_5 40-1,0.5016273366203506,
AH2018_LFQ_3_X,0.5052300300002932,
UK2020_UA_3,0.5048848431959585,
LY2019_P7-,0.49882942645441236,
GF2025_P5_Adh,0.5053663971069957,
RB2022_1_PostStrength,0.4884681047015597,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.5064897640362493,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.4956106414889836,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.5066311815646777,
PG2020_Intensity CT_B,,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.5043705522178086,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,0.5042584630978355,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.5067761707094041,
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.48936982854816413,
RB2022_2_PreEndurance,0.5042050245552945,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.5007388413450687,0.3384866009717087
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,0.4955182412786934,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,0.4999571540433376,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,0.5007479046029181,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.5056368900591127,
AH2018_TMTMS2_1_X,0.5075960905511137,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,0.502192322974361,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,0.5104948302724832,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.5042863078015868,
HS2024_4_I_T3,0.5064378237195682,
AH2018_SILAC_1_X,0.5060382389516841,
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,0.5100730456826452,
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,0.4939617182517231,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.4950482867436927,
HS2024_5_I_N2,0.5013506832096208,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.5013312846436839,
AS2011_Ratio H/L Normalized RNAi_2_1,,
